Paul Kenna

Fondatore presso Spark Therapeutics Ireland Ltd.

Consumer Services

Health Technology

Posizioni attive di Paul Kenna

Società	Posizione	Inizio	Fine
Spark Therapeutics Ireland Ltd. Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland.	Direttore Tecnico/Scientifico/R&S	01/09/2004	-
	Fondatore	-	-
Trinity College Dublin	Corporate Officer/Principal	-	-
The Royal College of Physicians	Corporate Officer/Principal	-	-
Irish College of Ophthalmologists	Corporate Officer/Principal	-	-

Trinity College Dublin

Doctorate Degree

Distribuzione geografica

Irlanda	4
Regno Unito	2

Posizioni

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	1
Founder	1

Settori

Consumer Services	4
Health Technology	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	1
Spark Therapeutics Ireland Ltd. Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland.	Health Technology

Aziende private

Health Technology